摘要
对罗非昔布原料药的合成工艺进行优化,为以罗非昔布为原料的研究奠定基础。苯甲硫醚经傅克乙酰化得1-[4-(甲硫基)苯基]-乙酮(3),化合物3在冰醋酸中直接用双氧水氧化得1-[4-(甲磺酰基)苯基]-乙酮(4),无需纯化,直接以溴素溴化,最后与苯乙酸缩合、环合生成COX-2选择性抑制剂罗非昔布(1)。研究了影响每步反应的因素,包括溶剂的选择、反应温度与反应时间的考察、催化剂用量选择、后处理等,总收率为62%。
The synthetic technology of rofecoxib was optimized, which laid the foundation for the study withroofecoxib as raw material. 1-(4-methylsulfanyl-phenyl) -ethanone (13) was obtained by thioanisole via Friedel craftsacetylation. Then it was oxidized with hydrogen peroxide in acetic acid to obtain 1 - (4 -methanesulfonyl - phenyl) -ethanone ( 14 ) . Without purification, it was bromized with bromine. Then it was condensed and cyclized withphenylacetic acid to generate COX-2 selective inhibitor rofecoxib (1). Various reaction factors were studied, includingthe choice of solvent, reaction temperature and reaction time, catalyst dosage, treatment after reaction, and the overallyield was 62%.
作者
刘改枝
田效志
贾永艳
关延彬
张京玉
LIU Gai-zhi, TIAN Xiao-zhi, JIA Yong-yan, GUAN Yan-bin, ZHANG Jing-yu(College of Pharmacy, Henan University of Chinese Medicine, Henan Zhengzhou 450046, Chin)
出处
《广州化工》
CAS
2018年第15期45-46,60,共3页
GuangZhou Chemical Industry
基金
河南省高等学校重点科研基金(No.16A350001)